Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

NCT00444925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1712

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: fesoterodine fumarate
DRUG: placebo
DRUG: tolterodine tartrate

Sponsor

Pfizer